At the end of the latest market close, Sangamo Therapeutics Inc. (SGMO) was valued at $11.03. In that particular session, Stock kicked-off at the price of $11.00 while reaching the peak value of $11.09 and lowest value recorded on the day was $9.34. The stock current value is $9.99.
Recently in News on August 10, 2020, Sangamo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Conference. Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present at the 2020 Wedbush PacGrow Healthcare Conference on August 12, 2020 at 2:55 p.m. Eastern Time. You can read further details here
Sangamo Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $13.20 on 08/19/20, with the lowest value was $4.81 for the same time period, recorded on 03/17/20.
Sangamo Therapeutics Inc. (SGMO) full year performance was -4.54%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Sangamo Therapeutics Inc. shares are logging -24.28% during the 52-week period from high price, and 107.80% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.81 and $13.20.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4437306 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Sangamo Therapeutics Inc. (SGMO) recorded performance in the market was 19.41%, having the revenues showcasing -13.24% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.40B, as it employees total of 354 workers.
Market experts do have their say about Sangamo Therapeutics Inc. (SGMO)
During the last month, 5 analysts gave the Sangamo Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 10.25, with a change in the price was noted +2.53. In a similar fashion, Sangamo Therapeutics Inc. posted a movement of +33.98% for the period of last 100 days, recording 2,079,066 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SGMO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Sangamo Therapeutics Inc. (SGMO)
Raw Stochastic average of Sangamo Therapeutics Inc. in the period of last 50 days is set at 31.66%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 16.97%. In the last 20 days, the company’s Stochastic %K was 12.84% and its Stochastic %D was recorded 13.49%.
Bearing in mind the latest performance of Sangamo Therapeutics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 19.41%. Additionally, trading for the stock in the period of the last six months notably improved by 22.94%, alongside a downfall of -4.54% for the period of the last 12 months. The shares increased approximately by -11.47% in the 7-day charts and went up by -13.39% in the period of the last 30 days. Common stock shares were lifted by -13.24% during last recorded quarter.